Clinical Outcomes of Patients with LAL+ in At Least One Eye

Enrolling by invitationOBSERVATIONAL
Enrollment

25

Participants

Timeline

Start Date

October 16, 2024

Primary Completion Date

January 1, 2025

Study Completion Date

February 1, 2025

Conditions
IOL, Cataract
Interventions
DEVICE

Light Adjustable Lens+

The Light Adjustable Lens+ (LAL+) is a posterior chamber, UV absorbing, three-piece, foldable, photo reactive silicone intraocular lens with a squared-posterior optic edge intended to be implanted in the capsular bag following phacoemulsification. Selective exposure to the implanted LAL+ using the Light Delivery Device (LDD) to deliver a spatially profiled UV light produces modifications in the lens curvature resulting in a spherical or spherocylindrical power change postoperatively. A subsequent lock-in exposure is delivered to the implanted LAL+ to stabilize the lens power. The LAL+ has a modified aspheric anterior surface that creates a small continuous increase in central lens power, which is designed to slightly extend the depth of focus.

Trial Locations (1)

18702

Bucci Laser Vision Institute, Wilkes-Barre

All Listed Sponsors
lead

Frank A. Bucci, Jr., M.D.

OTHER